These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 11444876)
1. Carnitine palmitoyl transferase I and the control of beta-oxidation in heart mitochondria. Eaton S; Bartlett K; Quant PA Biochem Biophys Res Commun; 2001 Jul; 285(2):537-9. PubMed ID: 11444876 [TBL] [Abstract][Full Text] [Related]
2. Carnitine palmitoyl transferase I and the control of myocardial beta-oxidation flux. Eaton S; Fukumoto K; Paladio Duran N; Pierro A; Spitz L; Quant PA; Bartlett K Biochem Soc Trans; 2001 May; 29(Pt 2):245-50. PubMed ID: 11356163 [TBL] [Abstract][Full Text] [Related]
3. Evidence of a malonyl-CoA-insensitive carnitine palmitoyltransferase I activity in red skeletal muscle. Kim JY; Koves TR; Yu GS; Gulick T; Cortright RN; Dohm GL; Muoio DM Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1014-22. PubMed ID: 11934665 [TBL] [Abstract][Full Text] [Related]
4. Regulation of CPT I activity in intermyofibrillar and subsarcolemmal mitochondria from human and rat skeletal muscle. Bezaire V; Heigenhauser GJ; Spriet LL Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E85-91. PubMed ID: 12954596 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis. Aires CC; Ijlst L; Stet F; Prip-Buus C; de Almeida IT; Duran M; Wanders RJ; Silva MF Biochem Pharmacol; 2010 Mar; 79(5):792-9. PubMed ID: 19854160 [TBL] [Abstract][Full Text] [Related]
6. tBid induces alterations of mitochondrial fatty acid oxidation flux by malonyl-CoA-independent inhibition of carnitine palmitoyltransferase-1. Giordano A; Calvani M; Petillo O; Grippo P; Tuccillo F; Melone MA; Bonelli P; Calarco A; Peluso G Cell Death Differ; 2005 Jun; 12(6):603-13. PubMed ID: 15846373 [TBL] [Abstract][Full Text] [Related]
7. Functional studies of yeast-expressed human heart muscle carnitine palmitoyltransferase I. Zhu H; Shi J; de Vries Y; Arvidson DN; Cregg JM; Woldegiorgis G Arch Biochem Biophys; 1997 Nov; 347(1):53-61. PubMed ID: 9344464 [TBL] [Abstract][Full Text] [Related]
8. Partial characterization of a malonyl-CoA-sensitive carnitine O-palmitoyltransferase I from Macrobrachium borellii (Crustacea: Palaemonidae). LavarÃas S; Pasquevich MY; Dreon MS; Heras H Comp Biochem Physiol B Biochem Mol Biol; 2009 Apr; 152(4):364-9. PubMed ID: 19171199 [TBL] [Abstract][Full Text] [Related]
9. Interacting effects of L-carnitine and malonyl-CoA on rat liver carnitine palmitoyltransferase. Bird MI; Saggerson ED Biochem J; 1985 Aug; 230(1):161-7. PubMed ID: 4052033 [TBL] [Abstract][Full Text] [Related]
10. Pig muscle carnitine palmitoyltransferase I (CPTI beta), with low Km for carnitine and low sensitivity to malonyl-CoA inhibition, has kinetic characteristics similar to those of the rat liver (CPTI alpha) enzyme. Relat J; Nicot C; Gacias M; Woldegiorgis G; Marrero PF; Haro D Biochemistry; 2004 Oct; 43(39):12686-91. PubMed ID: 15449958 [TBL] [Abstract][Full Text] [Related]
11. Impact of protein restriction on the regulation of cardiac carnitine palmitoyltransferase by malonyl-CoA. Holness MJ; Priestman DA; Sugden MC J Mol Cell Cardiol; 1998 Jul; 30(7):1381-90. PubMed ID: 9710806 [TBL] [Abstract][Full Text] [Related]
12. Effects of DL-2-bromopalmitoyl-CoA and bromoacetyl-CoA in rat liver and heart mitochondria. Inhibition of carnitine palmitoyltransferase and displacement of [14C]malonyl-CoA from mitochondrial binding sites. Edwards MR; Bird MI; Saggerson ED Biochem J; 1985 Aug; 230(1):169-79. PubMed ID: 4052034 [TBL] [Abstract][Full Text] [Related]
13. Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. McGarry JD; Mills SE; Long CS; Foster DW Biochem J; 1983 Jul; 214(1):21-8. PubMed ID: 6615466 [TBL] [Abstract][Full Text] [Related]
15. The malonyl CoA axis as a potential target for treating ischaemic heart disease. Ussher JR; Lopaschuk GD Cardiovasc Res; 2008 Jul; 79(2):259-68. PubMed ID: 18499682 [TBL] [Abstract][Full Text] [Related]
16. Binding of [14C]malonyl-CoA to rat liver mitochondria after blocking of the active site of carnitine palmitoyltransferase I. Displacement of low-affinity binding by palmitoyl-CoA. Grantham BD; Zammit VA Biochem J; 1986 Jan; 233(2):589-93. PubMed ID: 3954755 [TBL] [Abstract][Full Text] [Related]
17. Malonyl CoA inhibition of carnitine palmityltransferase in rat heart mitochondria. Paulson DJ; Ward KM; Shug AL FEBS Lett; 1984 Oct; 176(2):381-4. PubMed ID: 6489524 [TBL] [Abstract][Full Text] [Related]
18. Effect of malonyl-CoA on the kinetics and substrate cooperativity of membrane-bound carnitine palmitoyltransferase of rat heart mitochondria. Fiol CJ; Kerner J; Bieber LL Biochim Biophys Acta; 1987 Dec; 916(3):482-92. PubMed ID: 3689805 [TBL] [Abstract][Full Text] [Related]
19. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids. Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064 [TBL] [Abstract][Full Text] [Related]
20. C75 [4-methylene-2-octyl-5-oxo-tetrahydro-furan-3-carboxylic acid] activates carnitine palmitoyltransferase-1 in isolated mitochondria and intact cells without displacement of bound malonyl CoA. Yang N; Kays JS; Skillman TR; Burris L; Seng TW; Hammond C J Pharmacol Exp Ther; 2005 Jan; 312(1):127-33. PubMed ID: 15356215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]